FindTrial
Sign In

Application of oxycodone combined with abdominal wall nerve block preemptive analgesia in Da Vinci robot-assisted radical gastrectomy for gastric cancer

Application of oxycodone combined with abdominal wall nerve block preemptive analgesia in Da Vinci robot-assisted radical gastrectomy for gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069671
Enrollment
Unknown
Registered
2023-03-23
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Oxycodone group:Preemptive analgesia with oxycodone
Sufentanil group:Preemptive analgesia with sufentanil

Sponsors

Weifang People 's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients aged 18-65 years, ASA physical status I-II, BMI 18-35 kg / m2

Exclusion criteria

Exclusion criteria: ( 1 ) Patients who did not meet the inclusion criteria and were mistakenly included. ( 2) Patients with blood pressure fluctuations more than 20 % after admission, or long reintubation / intubation time, or no follow-up records. ( 3 ) Patients taking unspecified drug combinations, especially drugs that have a greater impact on clinical outcomes, efficacy and safety.

Design outcomes

Primary

MeasureTime frame
MAP and HR at each time point;Pain score at each time point after operation;—

Secondary

MeasureTime frame
Analgesic pump self-control times and adverse reactions of two groups;—

Countries

China

Contacts

Public ContactBao Lang

Weifang People 's Hospital

wfrmyy91@163.com+86 13515400823

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026